HIV drug resistance testing by NGS in real-life patients

被引：0
|
作者：
Sfalcin, J. A. [1 ]
Gomez, A. [1 ]
Seravalle, A. [1 ]
Fay, F. [1 ]
机构：
[1] Cib Lab, Mol Biol, Rosario, Santa Fe, Argentina
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2018年 / 73卷
关键词：
D O I：
10.1016/j.ijid.2018.04.3945
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
UMP. 353
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [21] EPIDEMIOLOGY OF DRUG-ABUSE AND REAL-LIFE EXPERIENCE
    FACY, F
    ANNALES DE MEDECINE INTERNE, 1994, 145 : 7 - 8
  • [22] Daclatasvir plasma concentration assessment in HIV-HCV-coinfected real-life patients
    Taton, Audrey
    Colson, Philippe
    Dhiver, Catherine
    Ruiz, Jean-Marie
    Bregigeon, Sylvie
    Tomei, Christelle
    Ressiot, Emmanuelle
    Menard, Amelie
    Poizot-Martin, Isabelle
    Ravaux, Isabelle
    Lacarelle, Bruno
    Solas, Caroline
    ANTIVIRAL THERAPY, 2017, 22 (08) : 731 - 733
  • [23] HIV resistance testing and detected drug resistance in Europe
    Schultze, Anna
    Phillips, Andrew N.
    Paredes, Roger
    Battegay, Manuel
    Rockstroh, Juergen K.
    Machala, Ladislav
    Tomazic, Janez
    Girard, Pierre M.
    Januskevica, Inga
    Gronborg-Laut, Kamilla
    Lundgren, Jens D.
    Cozzi-Lepri, Alessandro
    AIDS, 2015, 29 (11) : 1379 - 1389
  • [24] Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients
    Merchante, Nicolas
    Ibarra, Sofia
    Revollo, Boris
    Rodriguez-Arrondo, Francisco
    Merino, Esperanza
    Delgado-Fernandez, Marcial
    Montero-Alonso, Marta
    Tellez, Francisco
    Galindo, Maria J.
    Rivero-Juarez, Antonio
    Garcia, Maria A.
    Minguez, Carlos
    Romero-Palacios, Alberto
    Garcia-Deltoro, Miguel
    Pineda, Juan A.
    AIDS, 2017, 31 (01) : 89 - 95
  • [25] HIV-1 drug resistance and resistance testing
    Clutter, Dana S.
    Jordan, Michael R.
    Bertagnolio, Silvia
    Shafer, Robert W.
    INFECTION GENETICS AND EVOLUTION, 2016, 46 : 292 - 307
  • [26] Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy
    Mueller-Rebstein, Saskia
    Trenkwalder, Claudia
    Ebentheuer, Jens
    Oertel, Wolfgang H.
    Culmsee, Carsten
    Hoeglinger, Guenter U.
    CNS DRUGS, 2017, 31 (12) : 1093 - 1102
  • [27] Comparison of real-life data from patients with NGS panel negative and KRAS mutation positive metastatic lung adenocarcinoma
    Gokyer, Ali
    Kucukarda, Ahmet
    Kostek, Osman
    Gokmen, Ivo
    Ozcan, Erkan
    Sayin, Sezin
    Tastekin, Ebru
    Hacioglu, Bekir
    Erdogan, Bulent
    Uzunoglu, Sernaz
    Cicin, Irfan
    TUMORI JOURNAL, 2022, 108 (02): : 141 - 146
  • [28] Cannabidiol-drug interaction in cancer patients: A retrospective study in a real-life setting
    Guedon, Marie
    Le Bozec, Antoine
    Brugel, Mathias
    Clarenne, Justine
    Carlier, Claire
    Perrier, Marine
    Laurent, Maeliss
    Hettler, Dominique
    Mongaret, Celine
    Bouche, Olivier
    Slimano, Florian
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (07) : 2322 - 2328
  • [29] Drug Safety Analysis in a Real-Life Cohort of Parkinson’s Disease Patients with Polypharmacy
    Saskia Müller-Rebstein
    Claudia Trenkwalder
    Jens Ebentheuer
    Wolfgang H. Oertel
    Carsten Culmsee
    Günter U. Höglinger
    CNS Drugs, 2017, 31 : 1093 - 1102
  • [30] ANHEDONIA AND REAL-LIFE MOTIVATION IN PATIENTS WITH SCHIZOPHRENIA
    Chieffi, M.
    Piegari, G.
    Mucci, A.
    De Riso, F.
    De Simone, S.
    Plaitano, E.
    Nardi, A.
    Galderisi, S.
    EUROPEAN PSYCHIATRY, 2014, 29
12345